nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Hyperhidrosis—Triamcinolone—psoriasis	0.000296	0.000296	CcSEcCtD
Valganciclovir—Convulsion—Betamethasone—psoriasis	0.000295	0.000295	CcSEcCtD
Valganciclovir—Convulsion—Dexamethasone—psoriasis	0.000295	0.000295	CcSEcCtD
Valganciclovir—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000295	0.000295	CcSEcCtD
Valganciclovir—Insomnia—Hydrocortisone—psoriasis	0.000295	0.000295	CcSEcCtD
Valganciclovir—Hypertension—Dexamethasone—psoriasis	0.000294	0.000294	CcSEcCtD
Valganciclovir—Hypertension—Betamethasone—psoriasis	0.000294	0.000294	CcSEcCtD
Valganciclovir—Paraesthesia—Hydrocortisone—psoriasis	0.000292	0.000292	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000292	0.000292	CcSEcCtD
Valganciclovir—Urticaria—Cyclosporine—psoriasis	0.000291	0.000291	CcSEcCtD
Valganciclovir—Abdominal pain—Cyclosporine—psoriasis	0.00029	0.00029	CcSEcCtD
Valganciclovir—Body temperature increased—Cyclosporine—psoriasis	0.00029	0.00029	CcSEcCtD
Valganciclovir—Anxiety—Dexamethasone—psoriasis	0.000289	0.000289	CcSEcCtD
Valganciclovir—Anxiety—Betamethasone—psoriasis	0.000289	0.000289	CcSEcCtD
Valganciclovir—Vomiting—Mycophenolic acid—psoriasis	0.000288	0.000288	CcSEcCtD
Valganciclovir—Discomfort—Betamethasone—psoriasis	0.000287	0.000287	CcSEcCtD
Valganciclovir—Discomfort—Dexamethasone—psoriasis	0.000287	0.000287	CcSEcCtD
Valganciclovir—Dyspepsia—Hydrocortisone—psoriasis	0.000287	0.000287	CcSEcCtD
Valganciclovir—Haemoglobin—Methotrexate—psoriasis	0.000286	0.000286	CcSEcCtD
Valganciclovir—Dermatitis—Mycophenolic acid—psoriasis	0.000285	0.000285	CcSEcCtD
Valganciclovir—Pain—Prednisolone—psoriasis	0.000285	0.000285	CcSEcCtD
Valganciclovir—Haemorrhage—Methotrexate—psoriasis	0.000285	0.000285	CcSEcCtD
Valganciclovir—Hepatitis—Methotrexate—psoriasis	0.000285	0.000285	CcSEcCtD
Valganciclovir—Urticaria—Mycophenolate mofetil—psoriasis	0.000284	0.000284	CcSEcCtD
Valganciclovir—Headache—Mycophenolic acid—psoriasis	0.000284	0.000284	CcSEcCtD
Valganciclovir—Decreased appetite—Hydrocortisone—psoriasis	0.000283	0.000283	CcSEcCtD
Valganciclovir—Pharyngitis—Methotrexate—psoriasis	0.000283	0.000283	CcSEcCtD
Valganciclovir—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000283	0.000283	CcSEcCtD
Valganciclovir—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000283	0.000283	CcSEcCtD
Valganciclovir—Urinary tract disorder—Methotrexate—psoriasis	0.000281	0.000281	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000281	0.000281	CcSEcCtD
Valganciclovir—Fatigue—Hydrocortisone—psoriasis	0.000281	0.000281	CcSEcCtD
Valganciclovir—Vision blurred—Prednisone—psoriasis	0.00028	0.00028	CcSEcCtD
Valganciclovir—Urethral disorder—Methotrexate—psoriasis	0.000279	0.000279	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000279	0.000279	CcSEcCtD
Valganciclovir—Pain—Hydrocortisone—psoriasis	0.000278	0.000278	CcSEcCtD
Valganciclovir—Anaphylactic shock—Dexamethasone—psoriasis	0.000278	0.000278	CcSEcCtD
Valganciclovir—Oedema—Betamethasone—psoriasis	0.000278	0.000278	CcSEcCtD
Valganciclovir—Anaphylactic shock—Betamethasone—psoriasis	0.000278	0.000278	CcSEcCtD
Valganciclovir—Oedema—Dexamethasone—psoriasis	0.000278	0.000278	CcSEcCtD
Valganciclovir—Insomnia—Triamcinolone—psoriasis	0.000277	0.000277	CcSEcCtD
Valganciclovir—Infection—Dexamethasone—psoriasis	0.000276	0.000276	CcSEcCtD
Valganciclovir—Infection—Betamethasone—psoriasis	0.000276	0.000276	CcSEcCtD
Valganciclovir—Ill-defined disorder—Prednisone—psoriasis	0.000275	0.000275	CcSEcCtD
Valganciclovir—Paraesthesia—Triamcinolone—psoriasis	0.000275	0.000275	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisolone—psoriasis	0.000275	0.000275	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—psoriasis	0.000275	0.000275	CcSEcCtD
Valganciclovir—Anaemia—Prednisone—psoriasis	0.000274	0.000274	CcSEcCtD
Valganciclovir—Dyspnoea—Triamcinolone—psoriasis	0.000273	0.000273	CcSEcCtD
Valganciclovir—Nervous system disorder—Betamethasone—psoriasis	0.000273	0.000273	CcSEcCtD
Valganciclovir—Nervous system disorder—Dexamethasone—psoriasis	0.000273	0.000273	CcSEcCtD
Valganciclovir—Agitation—Prednisone—psoriasis	0.000273	0.000273	CcSEcCtD
Valganciclovir—Thrombocytopenia—Dexamethasone—psoriasis	0.000272	0.000272	CcSEcCtD
Valganciclovir—Thrombocytopenia—Betamethasone—psoriasis	0.000272	0.000272	CcSEcCtD
Valganciclovir—Tachycardia—Betamethasone—psoriasis	0.000272	0.000272	CcSEcCtD
Valganciclovir—Tachycardia—Dexamethasone—psoriasis	0.000272	0.000272	CcSEcCtD
Valganciclovir—Hypersensitivity—Cyclosporine—psoriasis	0.00027	0.00027	CcSEcCtD
Valganciclovir—Dyspepsia—Triamcinolone—psoriasis	0.00027	0.00027	CcSEcCtD
Valganciclovir—Nausea—Mycophenolic acid—psoriasis	0.000269	0.000269	CcSEcCtD
Valganciclovir—Hyperhidrosis—Dexamethasone—psoriasis	0.000269	0.000269	CcSEcCtD
Valganciclovir—Hyperhidrosis—Betamethasone—psoriasis	0.000269	0.000269	CcSEcCtD
Valganciclovir—Feeling abnormal—Hydrocortisone—psoriasis	0.000268	0.000268	CcSEcCtD
Valganciclovir—Malaise—Prednisone—psoriasis	0.000268	0.000268	CcSEcCtD
Valganciclovir—Vertigo—Prednisone—psoriasis	0.000267	0.000267	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—psoriasis	0.000266	0.000266	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000266	0.000266	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—psoriasis	0.000266	0.000266	CcSEcCtD
Valganciclovir—Anorexia—Dexamethasone—psoriasis	0.000265	0.000265	CcSEcCtD
Valganciclovir—Anorexia—Betamethasone—psoriasis	0.000265	0.000265	CcSEcCtD
Valganciclovir—Urticaria—Prednisolone—psoriasis	0.000265	0.000265	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—psoriasis	0.000264	0.000264	CcSEcCtD
Valganciclovir—Fatigue—Triamcinolone—psoriasis	0.000264	0.000264	CcSEcCtD
Valganciclovir—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000263	0.000263	CcSEcCtD
Valganciclovir—Asthenia—Cyclosporine—psoriasis	0.000263	0.000263	CcSEcCtD
Valganciclovir—Pain—Triamcinolone—psoriasis	0.000262	0.000262	CcSEcCtD
Valganciclovir—Hypotension—Betamethasone—psoriasis	0.00026	0.00026	CcSEcCtD
Valganciclovir—Hypotension—Dexamethasone—psoriasis	0.00026	0.00026	CcSEcCtD
Valganciclovir—Pruritus—Cyclosporine—psoriasis	0.000259	0.000259	CcSEcCtD
Valganciclovir—Urticaria—Hydrocortisone—psoriasis	0.000259	0.000259	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—psoriasis	0.000259	0.000259	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—psoriasis	0.000257	0.000257	CcSEcCtD
Valganciclovir—Abdominal pain—Hydrocortisone—psoriasis	0.000257	0.000257	CcSEcCtD
Valganciclovir—Body temperature increased—Hydrocortisone—psoriasis	0.000257	0.000257	CcSEcCtD
Valganciclovir—Convulsion—Prednisone—psoriasis	0.000257	0.000257	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—psoriasis	0.000257	0.000257	CcSEcCtD
Valganciclovir—Asthenia—Mycophenolate mofetil—psoriasis	0.000256	0.000256	CcSEcCtD
Valganciclovir—Hypertension—Prednisone—psoriasis	0.000256	0.000256	CcSEcCtD
Valganciclovir—Chills—Methotrexate—psoriasis	0.000256	0.000256	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000253	0.000253	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000253	0.000253	CcSEcCtD
Valganciclovir—Pruritus—Mycophenolate mofetil—psoriasis	0.000253	0.000253	CcSEcCtD
Valganciclovir—Arthralgia—Prednisone—psoriasis	0.000253	0.000253	CcSEcCtD
Valganciclovir—Feeling abnormal—Triamcinolone—psoriasis	0.000253	0.000253	CcSEcCtD
Valganciclovir—Anxiety—Prednisone—psoriasis	0.000252	0.000252	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—psoriasis	0.000252	0.000252	CcSEcCtD
Valganciclovir—Insomnia—Betamethasone—psoriasis	0.000252	0.000252	CcSEcCtD
Valganciclovir—Insomnia—Dexamethasone—psoriasis	0.000252	0.000252	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000251	0.000251	CcSEcCtD
Valganciclovir—Diarrhoea—Cyclosporine—psoriasis	0.000251	0.000251	CcSEcCtD
Valganciclovir—Paraesthesia—Betamethasone—psoriasis	0.00025	0.00025	CcSEcCtD
Valganciclovir—Paraesthesia—Dexamethasone—psoriasis	0.00025	0.00025	CcSEcCtD
Valganciclovir—Discomfort—Prednisone—psoriasis	0.00025	0.00025	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—psoriasis	0.00025	0.00025	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—psoriasis	0.000248	0.000248	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisolone—psoriasis	0.000246	0.000246	CcSEcCtD
Valganciclovir—Dyspepsia—Dexamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Valganciclovir—Dyspepsia—Betamethasone—psoriasis	0.000245	0.000245	CcSEcCtD
Valganciclovir—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000245	0.000245	CcSEcCtD
Valganciclovir—Urticaria—Triamcinolone—psoriasis	0.000244	0.000244	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—psoriasis	0.000243	0.000243	CcSEcCtD
Valganciclovir—Body temperature increased—Triamcinolone—psoriasis	0.000242	0.000242	CcSEcCtD
Valganciclovir—Dizziness—Cyclosporine—psoriasis	0.000242	0.000242	CcSEcCtD
Valganciclovir—Anaphylactic shock—Prednisone—psoriasis	0.000242	0.000242	CcSEcCtD
Valganciclovir—Oedema—Prednisone—psoriasis	0.000242	0.000242	CcSEcCtD
Valganciclovir—Decreased appetite—Dexamethasone—psoriasis	0.000242	0.000242	CcSEcCtD
Valganciclovir—Decreased appetite—Betamethasone—psoriasis	0.000242	0.000242	CcSEcCtD
Valganciclovir—Infection—Prednisone—psoriasis	0.000241	0.000241	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Betamethasone—psoriasis	0.00024	0.00024	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00024	0.00024	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—psoriasis	0.00024	0.00024	CcSEcCtD
Valganciclovir—Hypersensitivity—Hydrocortisone—psoriasis	0.00024	0.00024	CcSEcCtD
Valganciclovir—Fatigue—Dexamethasone—psoriasis	0.00024	0.00024	CcSEcCtD
Valganciclovir—Fatigue—Betamethasone—psoriasis	0.00024	0.00024	CcSEcCtD
Valganciclovir—Pain—Dexamethasone—psoriasis	0.000238	0.000238	CcSEcCtD
Valganciclovir—Pain—Betamethasone—psoriasis	0.000238	0.000238	CcSEcCtD
Valganciclovir—Nervous system disorder—Prednisone—psoriasis	0.000238	0.000238	CcSEcCtD
Valganciclovir—Tachycardia—Prednisone—psoriasis	0.000236	0.000236	CcSEcCtD
Valganciclovir—Dizziness—Mycophenolate mofetil—psoriasis	0.000236	0.000236	CcSEcCtD
Valganciclovir—Skin disorder—Prednisone—psoriasis	0.000235	0.000235	CcSEcCtD
Valganciclovir—Hyperhidrosis—Prednisone—psoriasis	0.000234	0.000234	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—psoriasis	0.000234	0.000234	CcSEcCtD
Valganciclovir—Asthenia—Hydrocortisone—psoriasis	0.000234	0.000234	CcSEcCtD
Valganciclovir—Vomiting—Cyclosporine—psoriasis	0.000233	0.000233	CcSEcCtD
Valganciclovir—Anorexia—Prednisone—psoriasis	0.000231	0.000231	CcSEcCtD
Valganciclovir—Dermatitis—Cyclosporine—psoriasis	0.000231	0.000231	CcSEcCtD
Valganciclovir—Pruritus—Hydrocortisone—psoriasis	0.00023	0.00023	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—psoriasis	0.00023	0.00023	CcSEcCtD
Valganciclovir—Headache—Cyclosporine—psoriasis	0.00023	0.00023	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—psoriasis	0.000229	0.000229	CcSEcCtD
Valganciclovir—Feeling abnormal—Dexamethasone—psoriasis	0.000229	0.000229	CcSEcCtD
Valganciclovir—Feeling abnormal—Betamethasone—psoriasis	0.000229	0.000229	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Betamethasone—psoriasis	0.000227	0.000227	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Dexamethasone—psoriasis	0.000227	0.000227	CcSEcCtD
Valganciclovir—Vomiting—Mycophenolate mofetil—psoriasis	0.000227	0.000227	CcSEcCtD
Valganciclovir—Hypersensitivity—Triamcinolone—psoriasis	0.000226	0.000226	CcSEcCtD
Valganciclovir—Dermatitis—Mycophenolate mofetil—psoriasis	0.000225	0.000225	CcSEcCtD
Valganciclovir—Headache—Mycophenolate mofetil—psoriasis	0.000224	0.000224	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—psoriasis	0.000224	0.000224	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—psoriasis	0.000223	0.000223	CcSEcCtD
Valganciclovir—Diarrhoea—Hydrocortisone—psoriasis	0.000223	0.000223	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—psoriasis	0.000222	0.000222	CcSEcCtD
Valganciclovir—Urticaria—Betamethasone—psoriasis	0.000221	0.000221	CcSEcCtD
Valganciclovir—Urticaria—Dexamethasone—psoriasis	0.000221	0.000221	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Prednisone—psoriasis	0.000221	0.000221	CcSEcCtD
Valganciclovir—Dizziness—Prednisolone—psoriasis	0.00022	0.00022	CcSEcCtD
Valganciclovir—Asthenia—Triamcinolone—psoriasis	0.00022	0.00022	CcSEcCtD
Valganciclovir—Body temperature increased—Betamethasone—psoriasis	0.00022	0.00022	CcSEcCtD
Valganciclovir—Abdominal pain—Betamethasone—psoriasis	0.00022	0.00022	CcSEcCtD
Valganciclovir—Abdominal pain—Dexamethasone—psoriasis	0.00022	0.00022	CcSEcCtD
Valganciclovir—Body temperature increased—Dexamethasone—psoriasis	0.00022	0.00022	CcSEcCtD
Valganciclovir—Insomnia—Prednisone—psoriasis	0.000219	0.000219	CcSEcCtD
Valganciclovir—Nausea—Cyclosporine—psoriasis	0.000218	0.000218	CcSEcCtD
Valganciclovir—Paraesthesia—Prednisone—psoriasis	0.000218	0.000218	CcSEcCtD
Valganciclovir—Pruritus—Triamcinolone—psoriasis	0.000217	0.000217	CcSEcCtD
Valganciclovir—Cough—Methotrexate—psoriasis	0.000216	0.000216	CcSEcCtD
Valganciclovir—Dizziness—Hydrocortisone—psoriasis	0.000215	0.000215	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—psoriasis	0.000215	0.000215	CcSEcCtD
Valganciclovir—Dyspepsia—Prednisone—psoriasis	0.000213	0.000213	CcSEcCtD
Valganciclovir—Nausea—Mycophenolate mofetil—psoriasis	0.000212	0.000212	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—psoriasis	0.000211	0.000211	CcSEcCtD
Valganciclovir—Decreased appetite—Prednisone—psoriasis	0.000211	0.000211	CcSEcCtD
Valganciclovir—Dermatitis—Prednisolone—psoriasis	0.00021	0.00021	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.00021	0.00021	CcSEcCtD
Valganciclovir—Fatigue—Prednisone—psoriasis	0.000209	0.000209	CcSEcCtD
Valganciclovir—Headache—Prednisolone—psoriasis	0.000209	0.000209	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—psoriasis	0.000209	0.000209	CcSEcCtD
Valganciclovir—Constipation—Prednisone—psoriasis	0.000207	0.000207	CcSEcCtD
Valganciclovir—Vomiting—Hydrocortisone—psoriasis	0.000207	0.000207	CcSEcCtD
Valganciclovir—Dermatitis—Hydrocortisone—psoriasis	0.000205	0.000205	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—psoriasis	0.000204	0.000204	CcSEcCtD
Valganciclovir—Headache—Hydrocortisone—psoriasis	0.000204	0.000204	CcSEcCtD
Valganciclovir—Dizziness—Triamcinolone—psoriasis	0.000203	0.000203	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—psoriasis	0.000202	0.000202	CcSEcCtD
Valganciclovir—Infection—Methotrexate—psoriasis	0.000201	0.000201	CcSEcCtD
Valganciclovir—Feeling abnormal—Prednisone—psoriasis	0.0002	0.0002	CcSEcCtD
Valganciclovir—Asthenia—Betamethasone—psoriasis	0.0002	0.0002	CcSEcCtD
Valganciclovir—Asthenia—Dexamethasone—psoriasis	0.0002	0.0002	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—psoriasis	0.000199	0.000199	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—psoriasis	0.000198	0.000198	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Prednisone—psoriasis	0.000198	0.000198	CcSEcCtD
Valganciclovir—Nausea—Prednisolone—psoriasis	0.000198	0.000198	CcSEcCtD
Valganciclovir—Pruritus—Betamethasone—psoriasis	0.000197	0.000197	CcSEcCtD
Valganciclovir—Pruritus—Dexamethasone—psoriasis	0.000197	0.000197	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—psoriasis	0.000197	0.000197	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—psoriasis	0.000196	0.000196	CcSEcCtD
Valganciclovir—Vomiting—Triamcinolone—psoriasis	0.000195	0.000195	CcSEcCtD
Valganciclovir—Nausea—Hydrocortisone—psoriasis	0.000193	0.000193	CcSEcCtD
Valganciclovir—Dermatitis—Triamcinolone—psoriasis	0.000193	0.000193	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—psoriasis	0.000193	0.000193	CcSEcCtD
Valganciclovir—Urticaria—Prednisone—psoriasis	0.000192	0.000192	CcSEcCtD
Valganciclovir—Headache—Triamcinolone—psoriasis	0.000192	0.000192	CcSEcCtD
Valganciclovir—Body temperature increased—Prednisone—psoriasis	0.000192	0.000192	CcSEcCtD
Valganciclovir—Abdominal pain—Prednisone—psoriasis	0.000192	0.000192	CcSEcCtD
Valganciclovir—Diarrhoea—Betamethasone—psoriasis	0.00019	0.00019	CcSEcCtD
Valganciclovir—Diarrhoea—Dexamethasone—psoriasis	0.00019	0.00019	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—psoriasis	0.000189	0.000189	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000184	0.000184	CcSEcCtD
Valganciclovir—Dizziness—Dexamethasone—psoriasis	0.000184	0.000184	CcSEcCtD
Valganciclovir—Dizziness—Betamethasone—psoriasis	0.000184	0.000184	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—psoriasis	0.000183	0.000183	CcSEcCtD
Valganciclovir—Nausea—Triamcinolone—psoriasis	0.000182	0.000182	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—psoriasis	0.000182	0.000182	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—psoriasis	0.000181	0.000181	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—psoriasis	0.00018	0.00018	CcSEcCtD
Valganciclovir—Hypersensitivity—Prednisone—psoriasis	0.000178	0.000178	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—psoriasis	0.000178	0.000178	CcSEcCtD
Valganciclovir—Vomiting—Dexamethasone—psoriasis	0.000177	0.000177	CcSEcCtD
Valganciclovir—Vomiting—Betamethasone—psoriasis	0.000177	0.000177	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—psoriasis	0.000176	0.000176	CcSEcCtD
Valganciclovir—Dermatitis—Betamethasone—psoriasis	0.000175	0.000175	CcSEcCtD
Valganciclovir—Dermatitis—Dexamethasone—psoriasis	0.000175	0.000175	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—psoriasis	0.000175	0.000175	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—psoriasis	0.000175	0.000175	CcSEcCtD
Valganciclovir—Headache—Betamethasone—psoriasis	0.000174	0.000174	CcSEcCtD
Valganciclovir—Headache—Dexamethasone—psoriasis	0.000174	0.000174	CcSEcCtD
Valganciclovir—Asthenia—Prednisone—psoriasis	0.000174	0.000174	CcSEcCtD
Valganciclovir—Pain—Methotrexate—psoriasis	0.000173	0.000173	CcSEcCtD
Valganciclovir—Pruritus—Prednisone—psoriasis	0.000171	0.000171	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—psoriasis	0.000167	0.000167	CcSEcCtD
Valganciclovir—Diarrhoea—Prednisone—psoriasis	0.000166	0.000166	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—psoriasis	0.000166	0.000166	CcSEcCtD
Valganciclovir—Nausea—Dexamethasone—psoriasis	0.000165	0.000165	CcSEcCtD
Valganciclovir—Nausea—Betamethasone—psoriasis	0.000165	0.000165	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—psoriasis	0.000161	0.000161	CcSEcCtD
Valganciclovir—Dizziness—Prednisone—psoriasis	0.00016	0.00016	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—psoriasis	0.00016	0.00016	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—psoriasis	0.00016	0.00016	CcSEcCtD
Valganciclovir—Vomiting—Prednisone—psoriasis	0.000154	0.000154	CcSEcCtD
Valganciclovir—Dermatitis—Prednisone—psoriasis	0.000153	0.000153	CcSEcCtD
Valganciclovir—Headache—Prednisone—psoriasis	0.000152	0.000152	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—psoriasis	0.000149	0.000149	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—psoriasis	0.000145	0.000145	CcSEcCtD
Valganciclovir—Nausea—Prednisone—psoriasis	0.000144	0.000144	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—psoriasis	0.000143	0.000143	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—psoriasis	0.000139	0.000139	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—psoriasis	0.000134	0.000134	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—psoriasis	0.000129	0.000129	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—psoriasis	0.000128	0.000128	CcSEcCtD
Valganciclovir—Headache—Methotrexate—psoriasis	0.000127	0.000127	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—psoriasis	0.00012	0.00012	CcSEcCtD
